✦ LIBER ✦

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer

✍ Scribed by Y. Tokuda; Masatoshi Ohta; Akira Okumura; Soichi Kuge; Mitsuhiro Kubota; Tomoo Tajima; Toshio Mitomi

Publisher: Springer
Year: 1997
Tongue: English
Weight: 129 KB
Volume: 40
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800051069

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early-onset secondary malignancies after

Early-onset secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation

✍ S. Fetscher; J. Finke; R. Engelhardt; R. Mertelsmann; W. Lange 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 140 KB

Tandem and triple high-dose chemotherapy

Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer

✍ J. Huober; A. Schneeweiss; S. Hohaus; G. Wittmann; A. Meyer; S. Martin; H. Golds 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 97 KB

Early versus late administration of pegf

Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation

✍ C. Kahl; H. G. Sayer; A. Hinke; M. Freund; J. Casper 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 303 KB

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer

✍ Lois J. Ayash 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

High-dose chemotherapy with autologous h

High-dose chemotherapy with autologous hematopoietic stem-cell rescue for patients with malignant brain tumors

✍ Masato Kochi; Yukitaka Ushio 📂 Article 📅 1999 🏛 Springer ⚖ 91 KB

Survival after autologous hematopoietic

Survival after autologous hematopoietic stem cell transplantation for patients with inflammatory breast carcinoma

✍ Banu Arun; Rebecca Slack; Edmund Gehan; Thomas Spitzer; Kenneth R. Meehan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## BACKGROUND. The authors retrospectively determined the clinical outcome of patients with inflammatory breast carcinoma (IBC) treated with high dose chemotherapy (HDC) and autologous bone marrow (ABM) or peripheral blood stem cell (PBSC) support. ## METHODS. Twenty-four consecutive patients w